Huttler Alexandra, Duvall Daniel, Sakkas Denny, Heyward Quetrell, Sabbagh Riwa, Alper Michael, Vaughan Denis
Boston IVF-IVIRMA Global Research Alliance, Waltham, Massachusetts; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts.
Boston IVF-IVIRMA Global Research Alliance, Waltham, Massachusetts.
Fertil Steril. 2025 Jul 23. doi: 10.1016/j.fertnstert.2025.07.029.
To identify the proportion of patients who would achieve ≥2 live births after a single in vitro fertilization (IVF) stimulation/embryo creation cycle.
Retrospective cohort study at a university-affiliated infertility practice.
Patients undergoing their first IVF cycle between January 1, 2014, and December 31, 2022.
Index oocyte retrieval cycle and subsequent autologous embryo transfer cycles.
Live births after autologous embryo transfer cycles from the index oocyte retrieval were analyzed, with additional live birth potential estimates extrapolated using age and oocyte number for those who had remaining frozen high-quality embryos. Univariable and multivariable logistic regression models were used to evaluate the association of known fertility factors with the outcome.
A total of 16,474 patients were included who underwent 20,710 total transfers during the study period. A total of 8,223 patients (49.9%) achieved ≥1 live birth, and 1,857 patients (11.3%) achieved ≥2 live births. Of note, 6,662 patients (40.4%) had a total of 24,067 remaining frozen high-quality embryos. Including estimates of additional live births resulting from use of remaining frozen embryos, 9,599 patients (58.3%; 95% confidence interval, 57.6%-59.1%) would achieve ≥1 live birth and 4,511 patients (27.3%; 95% confidence interval, 26.8%-28.0%) would achieve ≥2 live births. The proportion of patients achieving ≥2 live births progressively increased across groups of increasing oocyte yield and decreased with advancing age. Predictors of the odds of achieving ≥2 live births included age and number of oocytes retrieved. A total of 5,105 patients (31.0%) used preimplantation genetic testing for aneuploidy. Those who used preimplantation genetic testing for aneuploidy had a lower odds of achieving ≥2 live births.
With current IVF practices, over one fourth of patients could complete their families by achieving ≥2 live births from a single IVF stimulation cycle. The increasing number of oocytes retrieved and age of <35 years increased the odds of achieving this result. Providers can use these values as a counseling tool to guide shared decision-making to avoid additional stimulation cycles.
确定在单个体外受精(IVF)刺激/胚胎创建周期后实现≥2次活产的患者比例。
在一所大学附属不孕症治疗机构进行的回顾性队列研究。
2014年1月1日至2022年12月31日期间接受首次IVF周期治疗的患者。
首次取卵周期及随后的自体胚胎移植周期。
分析首次取卵后的自体胚胎移植周期后的活产情况,对于有剩余冷冻优质胚胎的患者,使用年龄和卵母细胞数量推断额外的活产潜力。使用单变量和多变量逻辑回归模型评估已知生育因素与结局之间的关联。
研究期间共纳入16474例患者,共进行了20710次移植。共有8223例患者(49.9%)实现了≥1次活产,1857例患者(11.3%)实现了≥2次活产。值得注意的是,6662例患者(40.4%)共有24067枚剩余冷冻优质胚胎。包括使用剩余冷冻胚胎导致的额外活产估计数,9599例患者(58.3%;95%置信区间,57.6%-59.1%)将实现≥1次活产,4511例患者(27.3%;95%置信区间,26.8%-28.0%)将实现≥2次活产。随着卵母细胞产量增加,实现≥2次活产的患者比例逐渐增加,且随着年龄增长而降低。实现≥2次活产几率的预测因素包括年龄和取卵数量。共有5105例患者(31.0%)使用了非整倍体植入前基因检测。使用非整倍体植入前基因检测的患者实现≥2次活产的几率较低。
按照当前的IVF治疗方法,超过四分之一的患者可以通过单个IVF刺激周期实现≥2次活产来完成生育。获取的卵母细胞数量增加以及年龄小于35岁会增加实现这一结果的几率。医疗服务提供者可将这些数据用作咨询工具,以指导共同决策,避免额外的刺激周期。